Evidence map›Paper›PMID 32764606›Full record

ArticleScientific reports2020

A novel formulation technology for baculoviruses protects biopesticide from degradation by ultraviolet radiation.

Kenneth Wilson, David Grzywacz, Igor Curcic, Freya Scoates, Karen Harper, Annabel Rice, Nigel Paul, Aoife Dillon

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Naturally Occurring Yeasts Associated withPathogens (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kenneth Wilson *Lancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, UK. ken.wilson@lancaster.ac.uk.
David Grzywacz *Department of Agriculture Health and Environment, Natural Resources Institute, University of Greenwich, Medway Campus, Central Avenue, Chatham Maritime, Kent, ME4 4TB, UK.
Igor CurcicExosect Limited, Leylands Business Park, Colden Common, Winchester, SO21 1TH, Hampshire, UK.
Freya ScoatesExosect Limited, Leylands Business Park, Colden Common, Winchester, SO21 1TH, Hampshire, UK.
Karen HarperLancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, UK.
Annabel RiceLancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, UK.
Nigel PaulLancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, UK.
Aoife DillonExosect Limited, Leylands Business Park, Colden Common, Winchester, SO21 1TH, Hampshire, UK.
Lancaster University · GBExosect Enabling Technologies · GBNatural Resources Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P004970/1
6 · The paper itself

Abstract

Biopesticides are biological pest control agents that are viewed as safer alternatives to the synthetic chemicals that dominate the global insecticide market. A major constraint on the wider adoption of biopesticides is their susceptibility to the ultraviolet (UV: 290-400 nm) radiation in sunlight, which limits their persistence and efficacy. Here, we describe a novel formulation technology for biopesticides in which the active ingredient (baculovirus) is micro-encapsulated in an ENTOSTAT wax combined with a UV absorbant (titanium dioxide, TiO

Indexed as

Pest Control, BiologicalAnimalsBaculoviridaeBiological AssayBrassicaInsectaSolanum lycopersicumUltraviolet Rays

Identifiers

PMID32764606
PMCPMC7411030
OpenAlexW3047066952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.